Composite pheochromocytoma-ganglioneuromas are rare adrenal tumors. They may be functional and while mostly sporadic, they may be associated with several genetic syndromes. Herein, we present the youngest reported patient with this tumor, which was incidentally discovered by CT scan performed prior to emergent appendectomy. The tumor was functional and she underwent a successful laparoscopic adrenalectomy with resolution of her biochemical abnormalities. Surgeons should be aware of this rare entity due to its uncertain long-term prognosis.
INTRODUCTION
A 20-year-old woman presented with a 3-week history of right lower quadrant pain that worsened acutely over a 2-day period prior to her presentation. She was evaluated and found to have low grade fever, right lower quadrant tenderness on physical examination and leukocytosis. Contrast-enhanced CT scan of the abdomen and pelvis revealed a 14 mm appendix that was not filled with air or contrast, periappendiceal fat stranding, and a fecalith in the midportion of the appendix, indicative of acute appendicitis. In addition, a 2.8 × 2.3 cm mass was identified arising from the medial limb of the right adrenal gland. The mass had heterogeneous enhancement on portal venous phase with no appreciable fat signal (Fig. 1A) . This was reported to be an indeterminate mass and further follow-up was recommended. Her past medical history was significant for hypertension with systolic blood pressures consistently greater than 140 mm Hg on previous evaluations. The diagnosis of pheochromocytoma was considered based on the appearance of the mass and the patient's symptoms. The findings and implications were discussed with the patient and the anesthesia team, and the decision was made to proceed with an appendectomy with careful monitoring of the patient's hemodynamic status. The anesthesia team secured peripheral intravenous access and an arterial line and Foley catheter were also placed. In addition, epinephrine, norepinephrine, nipride, esmolol and phentolamine were available for infusions and/or intermittent injection, as needed. The patient underwent an uneventful open appendectomy on the day of presentation and was found to have acute, nonperforated appendicitis. She was discharged within 23 hours of her procedure and recovered well.
She had a family history of diabetes in multiple relatives, a maternal grandfather with a pituitary tumor, and a maternal grandmother and aunts with thyroid disorders of unknown type. However, there was no known family history of adrenal tumors. Additional tests for adrenal hyperfunction revealed elevated dopamine (89 pg/ml, range 0-20), norepinephrine (3450 pg/ml, range 80-250) and free plasma normetanephrine levels (5.76 nmol/L, range < 0.90). Serum epinephrine and metanephrine levels were normal. A 24 hour urine collection for catecholamines and metabolites demonstrated elevated fractionated norepinephrine (663 μg/24 hours, range 16-125) and total metanephrine (1709 μg/24 hours, range 300-900) levels. She underwent an I-123 metaiodobenzylguanidine (MIBG) scan which showed an intense focus in the right adrenal mass and mild uptake in the left adrenal gland which was thought to be a physiologic variant. No extra-adrenal tumors were identified. Her calcitonin and serum calcium levels were normal.
She was prepared for surgery with phenoxybenzamine and metoprolol for preoperative blockade for a presumed pheochromocytoma. She underwent an uneventful laparoscopic right adrenalectomy via a transperitoneal lateral approach. The operative time was 134 minutes and the blood loss was minimal. Intraoperatively, she required pressors for a short duration after the adrenal vein was ligated, however, these were weaned off by the end of the surgery. Her postoperative course was uncomplicated. She was transferred to the surgical intensive care unit for postoperative monitoring and was discharged home on POD2. Her serum metanephrines had returned to normal levels at her initial postoperative visit. She did not wish to pursue genetic testing for MEN2 or VHL. She was doing well at her 2 weeks postoperative visit, but has since been lost to follow-up.
PATHOLOGY

Gross:
The overall specimen measured 6.5 × 4 × 2.2 cm and weighed 17 gm. Trimmed of fibroadipose tissue, the adrenal gland weighed 13 gm. Sectioning revealed a 2.7 × 2.2 × 1.6 cm well-circumscribed tan to red and vaguely nodular round mass arising from the medulla (Fig. 1B) .
Microscopy:
The majority of the neoplastic cells were characterized by uniformly large and round nuclei with fine chromatin and occasionally prominent nucleoli. These cells formed nests embedded in a neuropil background where isolated mature ganglion cells were identified. Other areas showed neoplastic cells more typical of a pheochromocytoma, with a fine vascular meshwork enclosing small nests of cells with pleomorphic nuclei and coarse chromatin (Figs 2A and B) . No spindle cells or immature neuroblasts were noted.
Immunohistochemistry: All tumor cells were positive for synaptophysin and chromogranin. Numerous fine nerve fibers were identified in the ganglioneuroma portion of the tumor on the neurofilament stain. The ganglion cells were positive for NeuN1, which highlighted the neuronal nature of the ganglion cells as well as many of the regular round cells in the neuropil (Figs 2C to E). In the pheochromocytoma portion of the tumor, the sustentacular cells in the zellballen nests of cells were positive for S-100. The mass was negative for pankeratin while the uninvolved adrenal cortex was positive for this stain.
DISCUSSION
The adrenal medulla is composed primarily of chromaffin cells, however, neuronal and glial cells are also present. The glial cells serve as supporting elements for the chromaffin and neuronal cells and include both sustentacular and classic Schwann cells. Pheochromocytomas can be combined with other tumors in approximately 3% of cases. These may be ganglioneuromas, malignant schwannomas or neuroendocrine carcinomas. These composite pheochromocytomas are extremely rare, with less than 60 cases cited in the English language literature.
The majority (> 70%) of composite pheochromocytomas are found in association with ganglioneuromas, and thus far only 41 cases of pheochromocytoma-ganglioneuromas have been reported (39 patients, summarized in Table 1 . [1] [2] [3] [4] [5] [6] [7] [8] The tumors appear to have a slight female preponderance (1.32:1), and were bilateral in approximately 5% of patients. The median age of patients at presentation was 54 years, although it ranged from 21 to 82 years. To our knowledge, our patient (age 20) is the youngest reported case of a composite pheochromocytoma-ganglioneuroma in the literature. Our case is also interesting as the patient underwent another emergent procedure without any complications prior to her adrenalectomy. Many patients with pheochromocytoma-paragangliomas have symptoms typical of classic pheochromocytomas as they produce catecholamines and their metabolites. 1 Patients may also rarely present with a watery diarrhea-hypokalemiaachlorhydria (WDHA) syndrome due to the secretion of vasoactive intestinal peptide (VIP). 1,3-5 Calcitonin production has also been reported. 1 Overall, 75% of patients have some preoperative evidence of functionality (Table 1) . Although our patient's tumor was clearly functional based on her laboratory studies, these were not available at the time of her appendectomy. However, the history and CT findings alerted the team to a possible pheochromocytoma, allowing for careful anesthetic management during that procedure. The importance of this is highlighted by reports of two patients with composite there did not appear to be any known family history of pheochromocytomas.
The diagnosis of composite pheochromocytoma is primarily made by pathology as their presentation and imaging features are similar to pheochromocytomas. Grossly, these tumors range from small and well-circumscribed nodules to larger lesions that may be hemorrhagic or necrotic. In many instances, the "mixed" nature of the tumor is only appreciated on microscopic examination. The tumors may be traversed by bundles of spindle cells which on immunohistochemical staining are Schwann cells, axons and prominent sustentacular cells. 9 Although chromogranin A, synaptophysin and other biosynthetic enzymes are expressed by both chromaffin cells and neurons, subtle differences in expression can yield useful information about cellular maturation and lineage. S-100 staining will identify Schwann cells and sustentacular cells. Normal and neoplastic human chromaffin cells have been shown to have increased VIP production as they undergo neuronal differentiation in vitro. In the normal adrenal, VIP is primarily a product of neuronal cells rather than chromaffin cells, however the latter can show VIP immunoreactivity. Tumors may also include a third component and at least two cases in the literature have included a cortical adenoma along with a composite pheochromocytomaganglioneuroma. 1, 8 There has been little long-term follow-up of patients with composite pheochromocytomas and the clinical course of these rare tumors have not been well established. Overall, the reported malignancy rate for composite tumors is about 25%, 1 and is typically associated with ganglioneuroblastomas, malignant peripheral nerve sheath components or neuroendocrine carcinomas. The reported risk of malignancy for pheochromocytoma-ganglioneuromas is much lower at about 3%, although follow-up is not always available ( Table 1 ). The risk of metastases from these tumors appears to arise more from the neural component rather than the pheochromocytoma and the presence of immature neuronal elements (indicating a neuroblastoma) is a poor prognostic indicator. Preoperatively, elevation in serum or urine dopamine or homovanillic acid should raise concern that the tumor contains immature neural elements and may thus be prone to recurrence and metastases. 10 DNA ploidy analysis has been shown to have variable utility in predicting the behavior of pure pheochromocytomas. In general, however, malignant tumors were usually aneuploid or nondiploid, and diploid tumors were usually benign. Lam et al 1 performed DNA ploidy analysis on three patients with pheochromocytoma-ganglioneuroma, one of whom also had metastatic disease. The pheochromocytoma component was aneuploid, whereas the ganglioneuroma portion was diploid.
In this patient, the metastases were composed of pheochromocytoma cells rather than ganglioneuroma indicating that the mature neuronal elements are less likely to metastasize. In tumors with composite ganglioneuroblastoma/ neuroblastoma, both tumor components have malignant potential. Due to the uncertain malignant potential of these tumors, long-term follow-up is advised.
CONCLUSION
We add to the series of composite pheochromocytomaganglioneuromas reported in the literature and furthermore, report on the successful management of the youngest reported patient with this tumor after emergent appendectomy. Surgeons, endocrinologists and pathologists must be familiar with this rare entity in the differential diagnosis of an incidentally discovered adrenal mass, which are being diagnosed with increasing frequency. In case a pheochromocytoma is suspected in a patient requiring an unrelated procedure, consideration must be given to delaying surgery until adequate blockade and resection of the pheochromocytoma can be performed. If it is necessary to proceed with an emergent procedure, close communication with an experienced anesthesia team is essential to a successful outcome.
